Cholestasis is associated with increased plasma glucocorticoid levels in mice.
Adrenalectomy lowers cholestasis-associated liver injury and hypercholesterolemia.
GR antagonist RU-486 similarly improves the cholestasis phenotype.
Endogenous glucocorticoids promote re-uptake of circulating bile acids into liver.